Your Search Results

New evidence for treatment of calcified coronary artery disease

20 May 2025 – From EuroPCR 2025

Explore the latest randomized trials and studies advancing the treatment of calcified coronary artery disease. This session covers cutting balloon use, lithotripsy versus conventional preparation, and one-year outcomes comparing rotational atherectomy, lithotripsy, and laser. Also highlighted is the EMPOWER CAD study focusing on women treated with...

New evidence for treatment of calcified coronary artery disease

How to deal with secondary mitral regurgitation in 2025?

20 May 2025 – From EuroPCR 2025

Delve into the evolving management of secondary mitral regurgitation, and the critical role of the Heart Team. This session replay presents the latest clinical trials, treatment guidelines, and a case-based discussion covering medical and interventional strategies, heart failure optimization, frailty assessment, and advanced imaging techniques.

How to deal with secondary mitral regurgitation in 2025?

Valve-in-valve and coronary protection

11 Sep 2025 – From PCR Rio Valves 2025

Explore complex valve-in-valve procedures and coronary protection strategies through a series of challenging case presentations. Topics include management of high-risk valve-in-valve scenarios, strategies for degenerated aortic bioprostheses, innovative transcarotid approaches, fenestration stenting for late coronary obstruction, and analysis of valve embolisation events, providing valuable insights for...

Novelties on how to manage difficult TAVI situations

11 Sep 2025 – From PCR Rio Valves 2025

Stay at the forefront of TAVI management with this session highlighting novel approaches to difficult clinical scenarios. Topics include predictive scoring for pacemaker implantation, impact of baseline frailty on recovery, comparative imaging for coronary stenosis evaluation, physiology-guided PCI in TAVI patients, and outcomes of extrathoracic non-transfemoral...

Tailored transfemoral TAVI in complex anatomies - LIVE Case

11 Sep 2025 – From PCR Rio Valves 2025

Supported by an unrestricted educational grant from Medtronic

An 89-year-old male with hypertension, dyslipidemia, current smoking, stage III kidney disease, and a history of diagonal PCI in 2010 presented with severe symptomatic aortic stenosis and a small annulus (410 mm²), with RBBB on ECG.

Via bilateral femoral access,...

Tailored transfemoral TAVI in complex anatomies - LIVE Case

Mitral valve - How to evaluate?

11 Sep 2025 – From PCR Rio Valves 2025

This educational session focuses on comprehensive evaluation of the mitral valve to guide clinical decision-making. Topics include risk stratification and patient selection for Mitral TEER, detailed anatomy review, assessment of primary and secondary mitral regurgitation phenotypes, advanced quantification techniques per current guidelines, and pre-intervention transoesophageal echocardiography...

Cardiac dimensions receives Medical Device Regulation (MDR) certification for Carillon Mitral Contour System

25 Apr 2023

Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study

19 Sep 2022

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Author

Pamela Gatto

Updates from the Intrepid Pilot Study: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Author

Nicola Ryan

Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)

03 Nov 2025

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.